149 related articles for article (PubMed ID: 36901940)
41. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
42. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression.
Feng Y; Li F; Yan J; Guo X; Wang F; Shi H; Du J; Zhang H; Gao Y; Li D; Yao Y; Hu W; Han J; Zhang M; Ding R; Wang X; Huang C; Zhang J
Life Sci; 2021 Dec; 287():120056. PubMed ID: 34687756
[TBL] [Abstract][Full Text] [Related]
43. Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms.
Jorge S; Capelo JL; LaFramboise W; Satturwar S; Korentzelos D; Bastacky S; Quiroga-Garza G; Dhir R; Wiśniewski JR; Lodeiro C; Santos HM
BMC Med; 2021 Sep; 19(1):196. PubMed ID: 34482820
[TBL] [Abstract][Full Text] [Related]
44. ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma.
Qiu X; Gu Y; Ni Y; Li Q
Biomed Res Int; 2020; 2020():2064582. PubMed ID: 33178820
[TBL] [Abstract][Full Text] [Related]
45. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
46. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
[TBL] [Abstract][Full Text] [Related]
47. Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.
Li QK; Pavlovich CP; Zhang H; Kinsinger CR; Chan DW
Semin Cancer Biol; 2019 Apr; 55():8-15. PubMed ID: 30055950
[TBL] [Abstract][Full Text] [Related]
48. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
Guan L; Tan J; Li H; Jin X
Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
[TBL] [Abstract][Full Text] [Related]
49. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.
Zheng J; Wang L; Peng Z; Yang Y; Feng D; He J
EBioMedicine; 2017 Feb; 15():62-72. PubMed ID: 27993630
[TBL] [Abstract][Full Text] [Related]
50. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
Shi B; Ding J; Qi J; Gu Z
Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
[TBL] [Abstract][Full Text] [Related]
51. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL
Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390
[TBL] [Abstract][Full Text] [Related]
52. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
53. Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.
Yin B; Zeng Y; Wang X; Liu G; Zhang M; Song Y
Int J Clin Exp Pathol; 2014; 7(7):4112-9. PubMed ID: 25120790
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma.
Cao Q; Ruan H; Wang K; Song Z; Bao L; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Liu D; Yang H; Chen K; Zhang X
Int J Oncol; 2018 Jul; 53(1):137-147. PubMed ID: 29749470
[TBL] [Abstract][Full Text] [Related]
55. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
56. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
[TBL] [Abstract][Full Text] [Related]
57. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
58.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
59. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
[TBL] [Abstract][Full Text] [Related]
60. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
Heyliger SO; Soliman KFA; Saulsbury MD; Reams RR
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
